Backes FJ - Search Results

1

RETRACTED: Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer.

Riedinger CJ, Barrington DA, Nagel CI, Khadraoui WK, Haight PJ, Tubbs C, Backes FJ, Cohn DE, O'Malley DM, Copeland LJ, Chambers LM. Riedinger CJ, et al. Among authors: backes fj. Gynecol Oncol. 2024 Apr;183:78-84. doi: 10.1016/j.ygyno.2024.03.020. Epub 2024 Mar 29. Gynecol Oncol. 2024. Retraction in: Gynecol Oncol. 2024 Apr;183:R1. doi: 10.1016/j.ygyno.2024.04.024 PMID: 38554477 Free article. Retracted.

2

Imaging across the life span: innovations in imaging and therapy for gynecologic cancer.

Xu-Welliver M, Yuh WT, Fielding JR, Macura KJ, Huang Z, Ayan AS, Backes FJ, Jia G, Moshiri M, Zhang J, Mayr NA. Xu-Welliver M, et al. Among authors: backes fj. Radiographics. 2014 Jul-Aug;34(4):1062-81. doi: 10.1148/rg.344130099. Radiographics. 2014. PMID: 25019442 Free PMC article.

3

Gynecologic Cancer Intergroup (GCIG) consensus review for ovarian germ cell tumors.

Brown J, Friedlander M, Backes FJ, Harter P, O'Connor DM, de la Motte Rouge T, Lorusso D, Maenpaa J, Kim JW, Tenney ME, Seckl MJ. Brown J, et al. Among authors: backes fj. Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S48-54. doi: 10.1097/IGC.0000000000000223. Int J Gynecol Cancer. 2014. PMID: 25341580 Review.

4

Programmed Death Ligand 1 Expression Among 700 Consecutive Endometrial Cancers: Strong Association With Mismatch Repair Protein Deficiency.

Li Z, Joehlin-Price AS, Rhoades J, Ayoola-Adeola M, Miller K, Parwani AV, Backes FJ, Felix AS, Suarez AA. Li Z, et al. Among authors: backes fj. Int J Gynecol Cancer. 2018 Jan;28(1):59-68. doi: 10.1097/IGC.0000000000001120. Int J Gynecol Cancer. 2018. PMID: 29053481

5

The Adrenal Gland as a Sanctuary Site of Metastases After Pembrolizumab Treatment: A Case Series.

Nguyen MC, Shah MH, Liebner DA, Backes FJ, Phay J, Shirley LA. Nguyen MC, et al. Among authors: backes fj. J Natl Compr Canc Netw. 2018 Nov;16(11):1279-1283. doi: 10.6004/jnccn.2018.7059. J Natl Compr Canc Netw. 2018. PMID: 30442730

6

Robotic trocar site small bowel evisceration after gynecologic cancer surgery.

Seamon LG, Backes F, Resnick K, Cohn DE. Seamon LG, et al. Obstet Gynecol. 2008 Aug;112(2 Pt 2):462-4. doi: 10.1097/AOG.0b013e3181719ba8. Obstet Gynecol. 2008. PMID: 18669765

7

Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer.

Richardson DL, Backes FJ, Seamon LG, Zanagnolo V, O'Malley DM, Cohn DE, Fowler JM, Copeland LJ. Richardson DL, et al. Among authors: backes fj. Gynecol Oncol. 2008 Dec;111(3):461-6. doi: 10.1016/j.ygyno.2008.08.011. Epub 2008 Sep 30. Gynecol Oncol. 2008. PMID: 18829088

8

Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer.

Backes FJ, Leon ME, Ivanov I, Suarez A, Frankel WL, Hampel H, Fowler JM, Copeland LJ, O'Malley DM, Cohn DE. Backes FJ, et al. Gynecol Oncol. 2009 Sep;114(3):486-90. doi: 10.1016/j.ygyno.2009.05.026. Epub 2009 Jun 10. Gynecol Oncol. 2009. PMID: 19515405

9

Are prediction models for Lynch syndrome valid for probands with endometrial cancer?

Backes FJ, Hampel H, Backes KA, Vaccarello L, Lewandowski G, Bell JA, Reid GC, Copeland LJ, Fowler JM, Cohn DE. Backes FJ, et al. Among authors: backes ka. Fam Cancer. 2009;8(4):483-7. doi: 10.1007/s10689-009-9273-5. Epub 2009 Jul 30. Fam Cancer. 2009. PMID: 19642020

10

Lynch syndrome screening strategies among newly diagnosed endometrial cancer patients.

Resnick K, Straughn JM Jr, Backes F, Hampel H, Matthews KS, Cohn DE. Resnick K, et al. Obstet Gynecol. 2009 Sep;114(3):530-536. doi: 10.1097/AOG.0b013e3181b11ecc. Obstet Gynecol. 2009. PMID: 19701031

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters